NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Proto Labs, Inc. ("Proto Labs") (NYSE:PRLB) concerning possible violations of federal securities laws.
On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower than expected guidance for Q4 2024. Proto attributed it to "a decline in our injection molding revenue, predominantly due to the challenging macroeconomic climate" in addition to the negative impacts of foreign currency and "the closure of [Proto's] Japan operation." Analysts were skeptical of Proto's explanation, pointing to increased competition as an alternate contributing factor for the decline.
Following this news, Proto's stock price fell by $11.09 per share to close at $24.62 per share. To obtain additional information, go to:
https://zlk.com/pslra-1/proto-labs-lawsuit-submission-form?prid=97654&wire=1
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212)363-7500.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212)363-7500
Fax: (212)363-7171
https://zlk.com/
SOURCE: Levi & Korsinsky, LLP